What are the most common side effects of sunitinib?

Sunitinib is a multi-target tyrosine kinase inhibitor that is widely used to treat malignant tumors such as advanced renal cell carcinoma, gastrointestinal stromal tumor (GIST), and pancreatic neuroendocrine tumors. As a targeted therapy drug, sunitinib can effectively inhibit the growth and angiogenesis of tumor cells, thereby delaying disease progression. However, while sunitinib exerts its efficacy, it is often accompanied by certain side effects. This article will detail the most common side effects of sunitinib to help patients and medical staff better understand and manage these adverse reactions.

First, fatigue is one of the most common side effects of sunitinib treatment. Most patients will feel fatigue to varying degrees during the medication process, which affects their daily life and work. The mechanism of fatigue is related to the effect of drugs on cell metabolism and the body's overall stress response. Although this type of fatigue is not usually life-threatening, ongoing fatigue may reduce a patient's quality of life and affect treatment compliance. To deal with fatigue, patients can relieve it through appropriate rest, reasonable arrangement of work and rest time, and nutritional support. At the same time, they need to inform their doctor to receive targeted intervention.

Secondly, gastrointestinal reactions are also common side effects of sunitinib, including nausea, vomiting, diarrhea and stomatitis. Nausea and vomiting may cause patients to lose appetite and weight, and in severe cases may even affect drug intake and absorption. Diarrhea may cause dehydration and electrolyte imbalance, and it is necessary to replenish water and electrolytes in time. Stomatitis manifests as oral mucosal pain and ulcers, affecting diet and quality of life. In response to these symptoms, doctors usually provide anti-nausea drugs, oral care and appropriate nutritional support. Patients should also avoid spicy and irritating foods and keep their mouths clean.

Third, skin reactions are also common side effects of sunitinib, mainly manifesting as rash, hand-foot syndrome (palm and plantar erythema, peeling, pain), and pigmentation. Hand-foot syndrome particularly affects the function of the patient's hands and feet, causing difficulty in walking and daily operations. The occurrence of skin side effects is related to drug damage to vascular endothelial cells and local inflammatory response. To reduce symptoms, patients should keep their skin clean and dry, avoid friction and irritation, use moisturizers and topical treatment ointments recommended by their doctors, and promptly report symptoms to their doctors to adjust their medication regimen.

In addition, sunitinib may also cause systemic side effects such as hypertension, hypothyroidism, abnormal liver function, and cardiotoxicity. Hypertension is relatively common during treatment, and blood pressure needs to be monitored regularly and antihypertensive drugs must be used as directed by your doctor. Hypothyroidism, which manifests itself as fatigue, weight gain, and a feeling of coldness, requires thyroid function tests to confirm the diagnosis and thyroid hormone supplementation. Abnormal liver function indicates impaired liver metabolism. In severe cases, the dose needs to be adjusted or medication suspended. Cardiotoxicity, although rare, may lead to cardiac dysfunction and patients require cardiac monitoring, especially those with a history of heart disease.

In summary, sunitinib plays an important role in targeted treatment of tumors, but its side effects are diverse and have a wide range of effects. Patients should maintain close observation during the medication period, and should report to the doctor in time if any discomfort occurs so that appropriate management measures can be taken. Reasonable side effect management can not only improve patients' treatment compliance, but also ensure treatment effects and quality of life. In the future, with in-depth research on the side effects of sunitinib, targeted prevention and treatment methods will continue to be improved to help patients receive treatment more safely and effectively.

Reference materials:https://www.sutent.com/